Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center
Date:
05/15/2023
Citation:
Smith L, Morris CP, Jibowu MH, Fallon S, Ray SC, Cosgrove SE, Curless MS, Fabre V, Karaba SM, Maragakis LL, Milstone AM, Sick-Samuels AC, Trexler P, Mostafa HH, Rock C; CDC Prevention Epicenter Program. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center. Infect Control Hosp Epidemiol. 2023 May;44(5):798-801. doi: 10.1017/ice.2022.37. Epub 2022 Mar 2. PMID: 35232508; PMCID: PMC8943229.
Abstract
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmissions among healthcare workers and hospitalized patients are challenging to confirm. Investigation of infected persons often reveals multiple potential risk factors for viral acquisition. We combined exposure investigation with genomic analysis confirming 2 hospital-based clusters. Prolonged close contact with unmasked, unrecognized infectious, individuals was a common risk.